Drugmakers losing a bid to foil generic painkillers

Public officials have long urged makers of powerful painkillers to do more to make the medications harder to crush and abuse. But now that some companies have done so, they want something in return—a ban on generic versions of the drugs they make that do not have such tamper-resistant designs.